Xoma
03:11 :
Post-Market NASDAQ Movers (HCKT, BRCD, MGAM, LEAP, XOMA , MTGE, CELL, ... -
The top after-market NASDAQ gainers Friday were The
Hackett Group, Inc., Brocade
Communications Systems, Inc.,
Multimedia Games Holding Company, Inc.,
Leap Wireless ...
20:19 :
Xoma zeroes in on diabetes — and a partnership? — again -
Research was on the chopping block as Xoma Corp. looked to cut costs over the past year. But now, even as takeover talk touches the Berkeley antibody drug developer, Xoma may be showing it was wise to cut elsewhere. In a paper published ...
13:03 :
Xoma seeks $39.2M from sale of stock, warrants -
Antibody drug developer Xoma Corp. would raise $39.2 million by selling nearly 29.7 million shares plus warrants. Berkeley-based Xoma (NASDAQ: XOMA) on Tuesday priced the common stock and warrants to buy one-half of a share of common ...
17:22 :
Xoma to sell stock to pay for clinical trials, layoff costs -
Xoma Corp. will sell an undisclosed amount of its common stock and warrants, the Berkeley antibody drug developer said Monday. Xoma (NASDAQ: XOMA) will use money from the sale to fund a shotgun full of clinical trials -- including ...
22:06 :
Xoma cuts deal for hypertension drug, potential combo products -
Xoma Corp. bought the U.S. rights to the hypertension drug Aceon — sold as a low-cost generic since 2009 — and up to three late-stage drug candidates that combine Aceon with other active ingredients, the Berkeley company said Tuesday. Xoma ...
actualidad Xoma -